Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Haemonetics Corporation Common Stock (NY: HAE )

62.36 +0.07 (+0.11%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Haemonetics Corporation Common Stock

< Previous 1 2 3 4 5 Next >
64 Biggest Movers From Yesterday
Check out these penny stocks insiders are buying Losers ION Geophysical Corporation (NYSE: IO) shares fell 53.6% to settle at $0.51 on Thursday. Epizyme, Inc. (NASDAQ:... 
Via Benzinga
75 Biggest Movers From Yesterday
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep. Check out these big penny stock gainers and losers... 
Via Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
Exposures Product Safety
What 8 Analyst Ratings Have To Say About Haemonetics
Analysts have provided the following ratings for Haemonetics (NYSE: 
Via Benzinga
46 Stocks Moving In Thursday's Mid-Day Session
Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 158.2% to $7.23 after tumbling 18% on Wednesday. Indonesia Energy said it projects to commence drilling... 
Via Benzinga
Why Haemonetics Stock Dived by 15% Today
The company broadly meets expectations for its Q2 2022 but trims its full-year guidance. 
Via The Motley Fool
Haemonetics Corp (HAE) Q2 2022 Earnings Call Transcript
HAE earnings call for the period ending October 2, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2022
Upgrades 
Via Benzinga
Looking Into Haemonetics's Return On Capital Employed
According to Benzinga Pro, during Q2, Haemonetics (NYSE:HAE) earned $24.51 million, a 398.43% increase from the preceding quarter. Haemonetics also posted a total of $239.90... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Compass Pathways (NASDAQ:CMPS) shares rose 18.43% to $51.0 during Tuesday's pre-market session. The company's market cap stands at $2.1 billion. As per the... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE: 
Via Benzinga
58 Stocks Moving In Monday's Mid-Day Session
Gainers Dover Motorsports, Inc. (NYSE: DVD) shares climbed 60.3% to $3.59 after Speedway Motorsports announced it will acquire the company for $3.61 per share in cash. TDH... 
Via Benzinga
Haemonetics' Vascade Vascular Closure Device Includes Same-Day Discharge Label
Haemonetics Corp's (NYSE: HAE) Vascade MVP Venous Vascular Closure System becomes the first vascular closure device to receive FDA indication for same-day discharge... 
Via Benzinga
Exposures Product Safety
Looking into Haemonetics's Return on Capital Employed
After pulling data from Benzinga Pro it seems like during Q1, Haemonetics (NYSE:HAE) posted sales of $228.53 million. Earnings were up 61.57%, but Haemonetics still reported an... 
Via Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... 
Via Benzinga
Haemonetics Corp (HAE) Q1 2022 Earnings Call Transcript
HAE earnings call for the period ending July 3, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out... 
Via Benzinga
Recap: Haemonetics Q1 Earnings
Shares of Haemonetics (NYSE:HAE) remained unaffected after the company reported Q1 results. Quarterly Results Earnings per share increased 8.70% year over year to $0.50,... 
Via Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks... 
Via Benzinga
Exposures Product Safety
Cramer Gives His Opinion On Virgin Galactic, Zynex And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said Virgin Galactic Holdings Inc (NYSE: SPCE) is a very expensive stock. It had a nice run, but he would look for... 
Via Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,... 
Via Benzinga
Exposures Product Safety
Why Haemonetics Stock Rallied on Friday
One analyst upgrade in particular seemed to bring back the bulls. 
Via The Motley Fool
What Does Haemonetics Debt Look Like?
Shares of Haemonetics (NYSE:HAE) fell by 57.47% in the past three months. Before having a look at the importance of debt, let us look at how much debt Haemonetics has.... 
Via Benzinga
A Look Into Haemonetics Price Over Earnings
In the current market session, Haemonetics Inc. (NYSE:HAE) is trading at $56.67, after a 9.38% increase. However, over the past month, the stock fell by 51.55%, and... 
Via Benzinga
Where Haemonetics Stands With Analysts
Analysts have provided the following ratings for Haemonetics (NYSE:HAE) within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 1 2 0 0... 
Via Benzinga
Why Haemonetics Stock Fell 13% Today
Investors don't seem to be buying the company's rosy 2022 guidance. 
Via The Motley Fool
Haemonetics Corp (HAE) Q4 2021 Earnings Call Transcript
HAE earnings call for the period ending April 3, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc... 
Via Benzinga
Exposures Product Safety
77 Biggest Movers From Yesterday
Gainers AMC Entertainment Holdings, Inc. (NYSE: AMC) shares surged 23.7% to close at $12.77. Moxian, Inc. (NASDAQ: MOXC) jumped 23.6% to close at $9.52. Repro Med Systems, Inc... 
Via Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
Gainers Reliance Global Group, Inc. (NASDAQ: RELI) jumped 38.7% to $4.0901 after the company said it has acquired a premier health insurance agency, J.P. Kush and Associates, Inc... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS